Delivery System Design in Topically Applied Formulations
Abstract
The skin provides a natural physical barrier against particle penetration. Delivery systems design can be used to overcome these barrier properties of the skin. One long-standing approach for improving topical drug delivery uses penetration enhancers which, penetrate into skin to reversibly decrease the barrier resistance. This review focuses on skin penetration pathways, different types of penetration enhancer and the technology for topical drug delivery as well as the probable mechanisms of action.
Keywords: Topical drug delivery, penetration enhancers
DOI
https://doi.org/10.22270/jddt.v8i6.2674References
Adrian C.W. and BrianW.B..(2004) Penetrationenhancers, Received 9 September2003; Anushka. (2005 )Anushka's New Innovation - CelluliteTreatment Censored LiposerumURL: [on line] August 26, 2005 avelebl at:http:// www.pr9.net/ business/ trade/ 2382august.html
Barr B.W. (2007) Transdermal drug delivery, in: M.E.Aulton(Ed.), Aulton'sPharma-ceutics, The Design and Manufacture of Medicines, thirded, Elsevier Churchill Livingstone, Edinburgh,,pp.580–585.
Barry B.W. ,(2001) Novel mechanisms and devices to enable successful transdermal drug delivery, Eur.J.Pharm.Sci.14,pp101–114.
Bernard. E., Dubois J. L., and Wepeirr, J., (1997)Importance of Sebaceous Glands in Cutaneous Penetration of an Antiandrogen: TargetEffect of Liposomes, J. Pharm. Sci., 86:573–578
Berner B. and Cooper E. R. (1987), Models of SkinPermeability, Transdermal Delivery ofDrugs, (A.F. Kydonieus and B. Berner, eds.)pp. 44
Bielinska A. V., Yen A., Zahos K. M., Sun R., Weiner N. D., Baker J. R., and Roessler B. J. (2000), Application of Mem-brane-based Dendrimer/DNA Complexes for Solid Phase Transfection In Vitro and In Vivo,Biomaterials, 21:877–887
Blanco P. ,Jalon D.,., M. J., Ygaruta,P., and Santoyo, S., (2002) Topical Application ofAcyclovir-loaded Micro Particles Quantifica-tion of the Drug in Porcine Skin Layers, J.Control Rel., 75:191–197
Bozena B. M.,Philip W. W.,Mohammad A.K.,Victor M. M.,(2005) Physiology and PenetrationPathways, Delivery System, Delivery System Handbook for Personal Care and Cosmetic Products, Edt, Meyer R. Rosen ,pp 78-85
Brandner J.M., McIntyre M., Kief S., Wladykowski E, Moll I.(2003) Expression and localization of tightjunction-associated proteins in human hairfollicles, Arch. Dermatol. Res.295,pp211–221.
Brown,V. K.(1964) “Structure and Function of epidermal Barriers” International Symposium, Brno, Czechoslovakia,
Dayan N., and Touitou E. (2000), Carriers for Skin Delivery of Triethexyphenidyl HCl: Ethosomesvs. Liposomes, Biomaterials, 21(18):1879–1885
Dayan. N. (2005) Pathways for Skin Penetration, New Jersey USA Vol. 120pp67-74
Dermal Administration of Methotrexate, Intl.J. Pharm., 270: pp119–125
Egbaria . K. and Weiner v.1990), Liposomes as a topical drug delivery system, Advanced Drug Delivery Reviews, 5 ,287-300
Elias P.M. and Feingold K.R., (1992) Lipids and the epidermal water barrier: metabolism, regulation, and pathophysiology, Semin.Dermatol.11,pp 176–182.
Fassihit.D , Muhiddinovt Z., Khalikovt D. and Speakerj T.(2004) Development and characterization of different lowmethoxy pectin microcapsules hy an emulsion-interfacereaction technique, Microencapsulation, , VOL. 21, NO. 7, 729-741
Fesq, H., et al., (2003) Improved Risk-benefit Rationfor Topical Triamcinolone Acetonide inTransferosome in Comparison with EquivalentCream and Ointment: A Randomized Con-trolled Trial, Br. J. Dermatol., 149:pp611–619
Finnin B.C., and morgan T.M. (1999) Transdermal Penetration Enhancers: Applications, Limitations, and Potential, J. of Pharmaceutical SciencesVol.88,No.10,pp 956.
Forster M., Bolzinger M.A., Fessi H., Briancon S., (2009) Topical delivery of cosmetics and drugs. Molecular aspects of Percutaneous absorption and delivery,Eur.J.Dermatol.pp1-36.
Geraldine G., Scott H. , Mike W., Stephen G. and Nava D. (2005)Microcapsules as a Delivery System, Delivery System Handbook for Personal Care and Cosmetic Products, Edt, Meyer R. Rosen,pp 192-213
Gupta N. B, Loona . S. and Khan,M. U.(2012) Ethosomes as elastic vesicles in transdermal drug delivery, IJPSR, Vol. 3, Issue 03.
Guy R.H and Hadgraft J.(1988)Physicochemical aspects of Percutaneous penetration and itsenhancement, Pharm. Res. 5pp753–758.
Guy,R.H. (1996) Currentstatus and future prospects of transdermal drug delivery. Pharm. Res; 13, pp1765-1769.
Hoffman R.M., (1998) Topical liposome targeting of dyes, melanins, genes, and protein selectively to hairfollicles, J.DrugTarget. 567–74.
Honeywell-N. (2003)Skin Penetration and Mechanism of Action in the Delivery of the D-2 Agonist Rotigotine from Surfactant Based Elastic Vesicles Formulations, Pharm.Res., 20:1619–1625
Honeywell-Nguyen, P. L. (2003), Skin Penetrationand Mechanism of Action in the Delivery ofthe D-2 Agonist Rotigotine from SurfactantBased Elastic Vesicles Formulations, Pharm.Res., 20:pp1619–1625
Ijeoma F, Uchegbu, Vyas S.P (1998): Non-ionic surfactant based vesicles in drug delivery. Int. J. Pharm.,; 172:pp 33-70.
Inayat B. P. and Mallikarjuna C. S(2009) Chemical Penetration Enhancers for Transdermal Drug Delivery Systems, J. of Pharmaceutical Research,; 8 (2):pp 173-179
Inayat B. P. and Mallikarjuna C. S , (2009)., Chemical Penetration Enhancers for Transdermal Drug Delivery Systems J. of Pharmaceutical Research, April ; 8 (2): pp173-179
Jain S. (2003), Jain P., Umamaheshwari R.B., Jain NK. Transferosomes: A novel vesicular carrier for enhanced transdermal delivery: Development, characterization and performance evaluation. Drug Dev Ind Pharm pp13-26
James V. Gruber, Louis P., and Peter D., (2005)Chronospheres®: Controlled Topical Actives Release Technology, Delivery System, Delivery System Handbook for Personal Care and Cosmetic Products, Edt, Meyer R. Rosen,pp353-364
John W. (2005) Microencapsulation, J. Polymer Sceince and Technology.pp1-29
Kadir F., Oussoren C. and Crommelin D. J . (1999), “Liposomal formulations to reduce irritation of intramuscularly andsubcutaneously administered drugs”, Injectable drug development, techniques to reduce pain and irritation(Eds PK Gupta and GABrazeau), Interpharm Press, Denver, Colorado, US, pp. 337–354.
Kasting G. B., Smith R. L.,Cooper E. R. (1987)Effect of Lipid Solubility and Molecular Size on Percutaneous Absorption, Skin Pharmacoki-netics, (B. Shroot and H. Schaefer, eds.), pp.138–153,
Katz M. (1973). Design of topical drug products :pharmaceutics, in :E.J. Ariens (Ed.),Drug Design, ,pp.93–148.
Kirschner N., Poetzl C., vondenDriesch P., Wladykowski E., Moll v, Behne M.J., Brandner v, (2009) Alteration of tight junction protein s is an early event in psoriasis: putative involve mentof proinflammatorycytokines,Am.J.Pathol.175 pp 1095.
Kligman A. M.(2000) Hydration Injury to HumanSkin: A View from the Horny Layer, Hand-book of Occupational Dermatology (L.Kanerva, P. Elsner, J. E. Wahlberg, and H. I.Maibach, eds.), pp. 76–8,
Kligman A.M (1965) Topical pharmacology and toxicology of dimethyl sulfoxide, J.Am. Med.Assoc. pp796.
Landfester., Musyanovych A., Guy R.H. (2010) Disposition of charged nanoparticles after their topical application to the skin, Skin Pharmacol.Physiol.23117–123.
Landh, T. (1994)., "Phase Behavior in the System Pine Needle Oil Monoglycerides-Poloxamer 407-Water at 20°," Journal of Physical Chemistry, 98 8453-67,
Lieb L.M, Ramachandran C, Egbaria K, Weiner ND (1992)Topical delivery enhancement with multilamellar liposomes via the pilosebaceous route: I. In vitro evaluation using fluorescent techniques with the hamster ear model. J Invest Dermatol pp108–113.
Lieb W. R. and Stein W. D., (1986)J. of MembraneBiol.,pp 92
Malkinson F. D.(1964), in “The Epidermis,” W. Montagna and W. C. Lobitz, Jr., Eds., Academic, New York, N.Y., , chap. 21.
MandawgadeS.D.and PatravaleV.B.( 2008) Development of SLNs from natural lipids: application to topical delivery of tretinoin. IntJPharm;v.8.EpubJul6,2008.
Marzulli F. N., Brown D. W. C., and Maibach H. I., (1969)Toxicol. Appl. Pharmacol., Suppl., 3,76
Matsen G. W.(1970) Minnesota Mining and Manu-facturing Company, US Patent 3,516,846 (Jun.23, 1970) and US Patent 3,516,941 (Jun. 23,1970)
Mcallister D. V., Kaushik S., Pate P. N., J. Mayberry L.,Allen M. G, and Prausnitz M. R., (1999) Solid and Hollow Microneedles for Transdermal Drug Delivery, Proc. 26th Intl.Symp. Control Rel. Bioact. Mater., Control.Release Soc, Deerfield,
Meyer R. R.(2005), The Delivery System Movement, Delivery System Handbook for Personal Care and Cosmetic Products,Edt, Meyer R. Rosen pp 8-9
Mezei M. and Gulasekharam V. (1980) Liposomes - a selective drug delivery system for the topical route of administration. I. Lotion dosage form, Life Sci. 26, pp1473-1477.
Mezei, M. and Gulasekharam, V. (1982) Liposomes - a selective drug delivery system for the topical route of administration: gel dosage form, J. Pharm. Pharmacol. 34,pp 473-474.
Michniak B. B, Wertz P.W., Mohammad A.and Meidan. V.M.(2005), Skin: Physiology and PenetrationPathways, edt. Meyer R. Rosen,pp76-85
Monte N.A. (2007) Riviere, Anatomica factors that affect barrier function, in: H.Zhai,K.P. Wilhelm,H.I. Maibach(Eds.), Marzulli and Maibach's Dermatotoxicology , seventhed., ,pp.39–50.
Monteiro R.N.2010, Structure and function ofskin,in: Monteiro N.A. Riviere(Ed.), Toxicology of the Skin, Informal Health careUSA,Inc.,NewYork, ,pp.1–18.
Moser K., Kriwet K.,.Naik A, Kalia Y.N.,.Guy R.H, (2001)Passive skin penetration enhancement and its quantification invitro,Eur.J.Pharm.Biopharm.52103–112.(P)
Nava D.(2005), Delivery System Design in TopicallyApplied Formulations, Delivery System, Delivery System Handbook for Personal Care and Cosmetic Products, Edt, Meyer R. Rosen,pp.102-116
Nordlund J. J., and Boissy R. E. (2000), The Biology of Melanocytes, The Biology of the Skin,R. K. Freinkel and D. T. Woodley, eds.,pp.113–131,
Paramjit S., sihorkar v., vikas j., kanaujia s. Vyas p. (2000) anatomical considerations and drug deliveryopportunities Journal of Pharmacology;32: pp 269-281
Parfitt, K. (1999) Salicylic Acid, Martindale,The Complete Drug Reference, 32nd Ed., pp.1090–1091
Patel R.( 2009), Singh, Singh S., Sheth N.K., Gendle R. Development and characterization of curcumin loaded transferosomes for transdermal Delivery. J Pharm Sci Res; pp71-80.
Pathan C.and Mallikarjuna S.(2009) Chemical Penetration Enhancers for Transdermal Drug Delivery Systems ,Journal of Pharmaceutical Research, ; 8 (2): pp173-179
PatravaleV.B and MandawgadeS.D.(2008),Novel cosmotic delivery system ,International journal of cosmotic Science.30,19-33
Patrick T. Spicer, atthew L. Lynch N, Steven B. Hoath and Marty O. Visscher, Bicontinuous Cubic Liquid Crystalline Phase and Cubosome, Personal Care Delivery Systems Edt, Meyer R. Rosenpp604-618
Priya B.,Diksha K.,Longsheng H.and Bozena B.Michnia K.(2007) .Transdermal Iontophoresis. [online]w.w.wcontroled release society.org.
ProwT.W., Grice J.E., Lin,R.Faye L.L., Butler M., Becker W., Wurm E.M., Yoong C., et.al, (2011)Nanoparticles and microparticles for skin drug delivery,Adv.DrugDeliv.Rev.63,470–491.
Rasool D., Elham R., Efat F. (2003) Gelatin Microspheres for the Controlled Release of All-trans-Retinoic Acid Topical Formulation and Drug Delivery Evaluation Iranian, J. of Pharmaceutical Research 47-50.
Rastogi S.K. and Singh J. (2001) Lipid extraction and transport of hydrophilic solutes through porcineepidermis, Int.J.Pharm.225 pp 75–82.
Riviere J.E ,(2006) Chemical mixtures, in:J. E.Riviere (Ed.), Dermal Absorption Models in Toxicology and Pharmacology ,pp.283–303.
Scheuplein. R.J. and Blank I.H. (1971)Permeability of the skin, Physiol.Rev.51pp702–747.
Schmidt R. J.(1989) Cutaneous Side Effects inTransdermal Drug Delivery: Avoidance Strat-egies. Transdermal Drug Delivery: Devel opmental Issues and Research Initiatives (J.Hadgraft and R.H. Guy, eds,) pp.
Schott H.(2000)., Colloidal Dispersions, Remington:The Science and Practice of Pharmacy, 20thEd. (A. R. Gennaro, ed.), pp. 294–304
Schugens C., Laruelle N., Nihant N., Grandfils C., Jerome R., Teyssie P. (1994): Journal Controlled Release, 32,161,
SharonF.,OferT.,KarineN.,NataliaL. and NavaD.( 2012) Alook at emerging delivery systems for topical drug products, inc.dermatologictherapyissn1396-0296 pp477-487.
Singh P.B, and Choudhury P.K. (2007) Penetration enhancers for transdermal drug delivery of systemic agents. J PharmRes 6:pp 44-50.
Smith S. P. (1962), British. Medical. J., 2,1233
Sojka, F. M., Dayan, N., Riemer, J., Ortega,L., Cummins, P., and Hawkins, S., (2003) Optically Activated Particles for the Reduction of the Appearance of Skin imperfections, Intl. Symp.Control Rel. Bioact. Mater., 072, Controlled Release Soc, Proc., Scotland 102-117
Sojka, F. M., Dayan, N., Riemer, J., Ortega,L., Cummins, P., and Hawkins, S., (2003) OpticallyActivated Particles for the Reduction of theAppearance of Skin Imperfections, Intl. Symp.Control Rel. Bioact. Mater., 072, ControlledRelease Soc, Proc., Scotland pp99-115
Tarl W., JeffreyE., LynleeL., RokhayaF., MargaretB., WolfgangB., ElisabethM., WurmeF, et.al (2011) Nanoparticles and microparticles for skin drugdelivery, Advanced Drug Delivery Reviews63 pp470–491
Terahara T., et al. (2002)Intl. J. Pharm., pp235
Trotta M., Peira E., Carlotti M. E., and Gallarate M. (2004) Deformable Liposomes for
Venkatesan P. et al ( 2009) /J. Pharm. Sci. & Res. Vol.1(4), pp26-35.
Verma, D. D., Verma, S., Blume, G., and Fahr,A., (2003) Liposomes Increase Skin Penetration ofEntrapped and Non-entrapped Hydrophilic Substances into Human Skin: A Skin Penetra-tion and Confocal Laser Scanning MicroscopyStudy, Eur. J. Pharm. Biopharm., 55:pp271–277
Wang Z.,ItohY,HosakaY.( 2003) Novel transdermal drug delivery system with poly hydroxy alkanoate and starburst polyamide amine dendrimer.JBiosciBioeng;pp95.
Watson.R.E., Poddar R., Walker J.M., McGuill I., Hoare L.M., Griffiths C.E., 'Neill C.A.O, (92007) Altered claudin expression is a feature of chronic plaque epsoriasis, J.Pathol. 212 pp450–458
William AC, Barry BW. (2004) Penetration enhancer. Adv Drug Deliv; 56:pp 603-618.
William G. Pitt D., Ghaleb A. Husseini, D., and Bryant J. Staples(2004) Ultrasonic Drug Delivery – A General Review edt.2004 November ; 1(1): pp37–56.
William G. Pitt, Dr., Ghaleb A. Husseini, Dr., and Bryant J. Staples Ultrasonic Drug Delivery ,Expert Opin Drug Deliv. Author manuscript; available in PMC 2006 February 6.
Williams P.L. and Riviere J.E.(1993) Model describing transdermal iontophoretic delivery of lidocaine incorporating consideration of cutaneous microvascular state, J.Pharm. Sci.82pp1080–1084.
Wohlrab, W. and Lasch, J. (1987) Penetration kinetics of liposomal hydrocortisone in human skin, Dermatologica 174, pp18-22.
Wolfgang M. and Jörg S. (2005), Delivery System, Delivery System Handbook for Personal Care and Cosmetic Products, Edt, Meyer R. Rosen,pp588-602
Wurster D. E. and. Kramer S. F, ( 1961). J. Pharm. Sci., 50, 288
Published
Abstract Display: 320 
PDF Downloads: 279 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.